NEDD9 adaptor protein regulates HER2-driven metastasis in breast cancer

被引：0
|
作者：
Kozyreva, Varvara [1 ,4 ]
Ice, Ryan [1 ,4 ]
Kiseleva, Anna [1 ]
Salkeni, Adham [1 ,3 ,4 ]
Choi, Hyeran [1 ]
Pugacheva, Elena [1 ,2 ,4 ]
机构：
[1] West Virginia Univ Canc Inst, Morgantown, WV USA
[2] Dept Biochem, Morgantown, WV USA
[3] Dept Med, Morgantown, WV USA
[4] Canc Cell Biol Program, Morgantown, WV USA
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2019年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [41] NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer
    Y V Loskutov
    P Y Kozyulina
    V K Kozyreva
    R J Ice
    B C Jones
    T J Roston
    M B Smolkin
    A V Ivanov
    R B Wysolmerski
    E N Pugacheva
    Oncogene, 2015, 34 : 3662 - 3675
  • [42] NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer
    Loskutov, Y. V.
    Kozyulina, P. Y.
    Kozyreva, V. K.
    Ice, R. J.
    Jones, B. C.
    Roston, T. J.
    Smolkin, M. B.
    Ivanov, A. V.
    Wysolmerski, R. B.
    Pugacheva, E. N.
    ONCOGENE, 2015, 34 (28) : 3662 - 3675
  • [43] NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway
    Liu, Wenhong
    Luo, Guanghua
    NEOPLASIA, 2024, 57
  • [44] A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice
    J L Little
    V Serzhanova
    E Izumchenko
    B L Egleston
    E Parise
    A J Klein-Szanto
    G Loudon
    M Shubina
    S Seo
    M Kurokawa
    M F Ochs
    E A Golemis
    Oncogene, 2014, 33 : 411 - 420
  • [45] A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice
    Little, J. L.
    Serzhanova, V.
    Izumchenko, E.
    Egleston, B. L.
    Parise, E.
    Klein-Szanto, A. J.
    Loudon, G.
    Shubina, M.
    Seo, S.
    Kurokawa, M.
    Ochs, M. F.
    Golemis, E. A.
    ONCOGENE, 2014, 33 (04) : 411 - 420
  • [46] A PERK inhibitor that blocks HER2-driven tumorigenesis and suppresses metastasis by targeting single disseminated tumor cells
    Calvo, Veronica
    Staschke, Kirk A.
    Paredes, Maria Cristina Garcia
    Avivar-Valderas, Alvaro
    Cheung, Julie
    Wild, Robert
    Rigby, Alan C.
    Farias, Eduardo F.
    Aguirre-Ghiso, Julio
    CANCER RESEARCH, 2016, 76
  • [47] Fhit expression protects against HER2-driven breast tumor development -: Unraveling the molecular interconnections
    Bianchi, Francesca
    Tagliabue, Elda
    Menard, Sylvie
    Campiglio, Manuela
    CELL CYCLE, 2007, 6 (06) : 643 - 646
  • [48] The Overexpression of Scaffolding Protein NEDD9 Promotes Migration and Invasion in Cervical Cancer via Tyrosine Phosphorylated FAK and SRC
    Sima, Ni
    Cheng, Xiaodong
    Ye, Feng
    Ma, Ding
    Xie, Xing
    Lu, Weiguo
    PLOS ONE, 2013, 8 (09):
  • [49] MEDI3379, an antibody against HER3, is active in HER2-driven human breast tumor models
    Xiao, Z.
    Rothstein, R.
    Carrasco, R.
    Wetzel, L.
    Kinneer, K.
    Chen, H.
    Tice, D.
    Hollingsworth, R.
    Steiner, P.
    CANCER RESEARCH, 2012, 72
  • [50] NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: Involvement in cancer progressiveness
    Morimoto, Kazuya
    Tanaka, Tomoaki
    Nitta, Yujiro
    Ohnishi, Keiko
    Kawashima, Hidenori
    Nakatani, Tatsuya
    PROSTATE, 2014, 74 (08): : 901 - 910
12345